Recommended Pain Medications for Acute Pain Management
For acute pain management, non-opioid therapies including NSAIDs and acetaminophen should be used first-line, with opioids reserved for severe pain when benefits outweigh risks. 1
Pain Medication Selection Algorithm
For Mild to Moderate Acute Pain:
First-line options:
- Non-COX specific NSAIDs (e.g., ibuprofen 400-600 mg orally every 4-6 hours) are recommended over codeine-acetaminophen combinations 1
- NSAIDs have better numbers needed to treat (2.7 for naproxen/ibuprofen vs 4.4 for codeine-acetaminophen) 1
- NSAIDs provide longer time to re-medication with safer side effect profiles 1, 2
- Acetaminophen 1000 mg (oral or IV) is an effective alternative, especially when NSAIDs are contraindicated 3, 2
Second-line options:
For Moderate to Severe Acute Pain:
First-line IV options:
Patient-controlled dosing:
Special Considerations
For Patients with Renal Impairment:
- Use all opioids with caution at reduced doses and frequency 1
- Fentanyl and buprenorphine (transdermal or IV) are the safest opioids for patients with chronic kidney disease stages 4 or 5 1
For Patients on Maintenance Opioid Therapy:
- Continue maintenance methadone therapy and add short-acting opioid analgesics when needed 1
- For patients on buprenorphine maintenance:
- Continue buprenorphine and titrate short-acting opioid analgesics to effect, OR
- Divide the daily buprenorphine dose and administer every 6-8 hours to utilize its analgesic properties 1
For Neuropathic Pain:
- First-line options include:
- Secondary-amine tricyclic antidepressants (nortriptyline, desipramine)
- Selective serotonin norepinephrine reuptake inhibitors (duloxetine, venlafaxine)
- Calcium channel α-2-δ ligands (gabapentin, pregabalin)
- Topical lidocaine for localized peripheral neuropathic pain 1
Common Pitfalls and Caveats
- Acetaminophen ceiling effect: Acetaminophen reaches an analgesic ceiling effect at 1000 mg; increasing to 2000 mg provides minimal additional benefit 4
- IV vs. oral administration: IV acetaminophen does not reduce morphine requirements compared to placebo in ED patients 5
- Codeine metabolism variations: Certain genotypes may not metabolize or may hyper-metabolize codeine due to CYP2D6 polymorphism, affecting efficacy and safety 1
- Combination products: Fixed-dose combinations of opioids with acetaminophen should be limited to avoid acetaminophen-induced hepatic toxicity in patients requiring large doses 1
- Opioid use: When opioids are necessary for severe pain, they should be prescribed at the lowest effective dose and for no longer than the expected duration of severe pain 1
- Oral loading strategy: Oral oxycodone solution (0.125 mg/kg) can provide similar pain relief to IV morphine (0.1 mg/kg) after 30 minutes, with shorter administration time but delayed onset 6